Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline
Crossref DOI link: https://doi.org/10.1186/s12872-017-0659-2
Published Online: 2017-08-16
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Journath, Gunilla https://orcid.org/0000-0002-5286-2062
Hambraeus, Kristina
Hagström, Emil
Pettersson, Billie
Löthgren, Mickael
Funding for this research was provided by:
Amgen AB, Sweden